Aneustat

OMN54 · Omnitura Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Aneustat, covering 2015-04-08 to 2015-04-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Aneustat (OMN54) in Patients With Advanced Cancer and Lymphomas [Phase 1]